Our Extended Family of Portfolio Companies

Investing in transformational ideas and entrepreneurial grit to solve major unmet needs in patient care

view more →

410 Medical is dedicated to developing innovative products that help emergency clinicians provide better care for critically ill patients.

view more →

Altis has developed a patent-pending stem cell technology recreating the human intestinal epithelium for compound screening and microbiome research.

view more →

Bivarus is a healthcare IT company that has developed an elegant and efficient patient survey platform. Acquired by Press Ganey Associates in January 2018.

view more →

The company’s small-molecule therapies focus on cyclin-dependent kinases and CDKs. IPO in May 2017 (NASDAQ: GTHX).

view more →

IMMvention is developing novel, first-in-class therapies for treating hemolytic anemias.

view more →

The SHAPE-MaP technology developed in the lab of Dr. Weeks identifies functional motifs within RNA by mapping the RNA three-dimensional structure.

view more →

Stridebio is developing engineered viral vectors for gene therapy. Acquired by Ginkgo Bioworks 2023

view more →

Synaptrix is focused on developing and commercializing drug-free, long-lasting solutions for post-operative pain management.

“It is not the critic who counts: not the man who points out how the strong man stumbles or where the doer of deeds could have done better. The credit belongs to the man who is actually in the arena, whose face is marred by dust and sweat and blood, who strives valiantly, who errs and comes up short again and again, because there is no effort without error or shortcoming, but who knows the great enthusiasms, the great devotions, who spends himself in a worthy cause; who, at the best, knows, in the end, the triumph of high achievement, and who, at the worst, if he fails, at least he fails while daring greatly, so that his place shall never be with those cold and timid souls who knew neither victory nor defeat.”


Theodore Roosevelt
Speech at the Sorbonne, Paris, April 23, 1910